Stocky
AMGN
Amgen Inc.
NASDAQ NMS - GLOBAL MARKET · Biotechnology · US
407.83
▲ +4.57%

What's happening at Amgen Inc.

Amgen Inc.'s latest moves, explained simply — so you know why the numbers change.

Straight from SEC filings · updated 6 Aug 2026
Big update 5 Aug 2026

Company reports cybersecurity risks from employee fraud and breaches

Security problems can hurt a company's reputation and expose sensitive data, potentially costing money and losing customer trust.

SEC 10-Q · filed 2026-08-05 View filing ↗
Earnings 4 Aug 2026

Amgen announces second quarter 2026 financial results

Quarterly earnings show whether a company is making money and growing, helping investors decide if it's a good investment.

SEC 8-K · filed 2026-08-04 View filing ↗
Governance 31 Jul 2026

Hackers access Amgen cloud data in July 2026 incident

Data breaches can cost companies money to fix and harm their business, but this one didn't affect products or operations yet.

SEC 8-K · filed 2026-07-31 View filing ↗
Governance 20 May 2026

Stockholders reelect 12 directors and approve executive compensation

Directors run the company, so who gets elected matters; shareholders voting shows owners have a say in leadership decisions.

SEC 8-K · filed 2026-05-20 View filing ↗
People 19 May 2026

New CFO Thomas Dittrich starts September 2026, replaces Griffith

The CFO manages money and finances, so leadership changes at this level can affect how well a company runs.

SEC 8-K · filed 2026-05-19 View filing ↗
Earnings 1 May 2026

Amgen files first quarter 2026 financial statements

Quarterly filings show investors detailed financial data needed to track a company's health and performance.

SEC 10-Q · filed 2026-05-01 View filing ↗
Earnings 30 Apr 2026

First quarter 2026 earnings released with non-GAAP measures

Earnings announcements tell investors if the company is making expected profits and how it compares to previous periods.

SEC 8-K · filed 2026-04-30 View filing ↗

Common questions

How does Stocky track Amgen Inc.'s company events?

Stocky reads Amgen Inc.'s official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.

What was Amgen Inc.'s most recent SEC filing?

Amgen Inc.'s most recent tracked filing was a 10-Q on 5 Aug 2026: Company reports cybersecurity risks from employee fraud and breaches.

Is this financial advice?

No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.

See Amgen Inc.'s full breakdown on Stocky →

Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 6 Aug 2026.